Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Feasibility and Safety of Intranasally Administered Breast Milk in HIE [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating feasibility and safety of intranasal breast milk for neonatal hypoxic-ischemic encephalopathy; currently recruiting at Semmelweis Unive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal breast milk (Breast milk, intranasal)

Snippet

Sponsor: Semmelweis University | Conditions: Hypoxic Ischaemic Encephalopathy (HIE), Hypoxic Ischemic Encephalopathy of Newborn | EARLY_Phase 1 | Status: RECRUITING